All news

CVS Health holds Moderate Buy with

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Analysts maintain a "Moderate Buy" rating on CVS Health Corporation (NYSE:CVS), with an average 12-month price target of

Read original source

CVS company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.